JPS6221357B2 - - Google Patents
Info
- Publication number
- JPS6221357B2 JPS6221357B2 JP16913980A JP16913980A JPS6221357B2 JP S6221357 B2 JPS6221357 B2 JP S6221357B2 JP 16913980 A JP16913980 A JP 16913980A JP 16913980 A JP16913980 A JP 16913980A JP S6221357 B2 JPS6221357 B2 JP S6221357B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- iodide
- chloride
- bromide
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- -1 steroid compound Chemical class 0.000 claims description 35
- 229910052751 metal Inorganic materials 0.000 claims description 9
- 239000002184 metal Substances 0.000 claims description 9
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 9
- 125000000217 alkyl group Chemical group 0.000 claims description 8
- 150000003983 crown ethers Chemical class 0.000 claims description 5
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 125000001174 sulfone group Chemical group 0.000 claims description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 3
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 claims description 3
- 238000005869 desulfonation reaction Methods 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims description 3
- 239000003444 phase transfer catalyst Substances 0.000 claims description 3
- 229910001515 alkali metal fluoride Inorganic materials 0.000 claims description 2
- 238000000034 method Methods 0.000 description 20
- 238000006243 chemical reaction Methods 0.000 description 11
- 150000001875 compounds Chemical class 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 6
- 239000004380 Cholic acid Substances 0.000 description 6
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 6
- 229960002471 cholic acid Drugs 0.000 description 6
- 235000019416 cholic acid Nutrition 0.000 description 6
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 6
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- RUDATBOHQWOJDD-UHFFFAOYSA-N (3beta,5beta,7alpha)-3,7-Dihydroxycholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 RUDATBOHQWOJDD-UHFFFAOYSA-N 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 5
- RUDATBOHQWOJDD-BSWAIDMHSA-N chenodeoxycholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-BSWAIDMHSA-N 0.000 description 5
- 229960001091 chenodeoxycholic acid Drugs 0.000 description 5
- 239000003054 catalyst Substances 0.000 description 4
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 239000007791 liquid phase Substances 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000002194 synthesizing effect Effects 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 125000006165 cyclic alkyl group Chemical group 0.000 description 3
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 3
- 235000011056 potassium acetate Nutrition 0.000 description 3
- 238000007086 side reaction Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- AGMVCZWYDXQPEM-UHFFFAOYSA-N (3-bromo-1,1-diphenylpropyl)benzene Chemical compound C1(=CC=CC=C1)C(CCBr)(C1=CC=CC=C1)C1=CC=CC=C1 AGMVCZWYDXQPEM-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 1
- XRNFDHBNDUQTNB-UHFFFAOYSA-N 1-[chloro(diphenyl)methyl]-2-phenylbenzene Chemical compound C=1C=CC=CC=1C(C=1C(=CC=CC=1)C=1C=CC=CC=1)(Cl)C1=CC=CC=C1 XRNFDHBNDUQTNB-UHFFFAOYSA-N 0.000 description 1
- PQXZDDANWHYJNO-UHFFFAOYSA-N 1-bromo-10,10-dibutyltetradecane Chemical compound C(CCC)C(CCCCCCCCCBr)(CCCC)CCCC PQXZDDANWHYJNO-UHFFFAOYSA-N 0.000 description 1
- JSWOGIMNIBKLOZ-UHFFFAOYSA-N 1-bromo-5,5-dibutylnonane Chemical compound CCCCC(CCCC)(CCCC)CCCCBr JSWOGIMNIBKLOZ-UHFFFAOYSA-N 0.000 description 1
- HKACRJSRNDVIJF-UHFFFAOYSA-N 1-butyl-2-(5-chlorononan-5-yl)benzene Chemical compound CCCCC1=CC=CC=C1C(Cl)(CCCC)CCCC HKACRJSRNDVIJF-UHFFFAOYSA-N 0.000 description 1
- VFTFKUDGYRBSAL-UHFFFAOYSA-N 15-crown-5 Chemical compound C1COCCOCCOCCOCCO1 VFTFKUDGYRBSAL-UHFFFAOYSA-N 0.000 description 1
- XEZNGIUYQVAUSS-UHFFFAOYSA-N 18-crown-6 Chemical compound C1COCCOCCOCCOCCOCCO1 XEZNGIUYQVAUSS-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- VQGOIINCSJEJOJ-UHFFFAOYSA-N 5-bromo-5-butylnonane Chemical compound CCCCC(Br)(CCCC)CCCC VQGOIINCSJEJOJ-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- CNEHONRSBZKTMT-UHFFFAOYSA-N 9-(bromomethyl)-9-octylheptadecane Chemical compound C(CCCCCCC)C(CBr)(CCCCCCCC)CCCCCCCC CNEHONRSBZKTMT-UHFFFAOYSA-N 0.000 description 1
- FEHVFVWKWSFHRK-UHFFFAOYSA-N 9-bromo-9-octylheptadecane Chemical compound CCCCCCCCC(Br)(CCCCCCCC)CCCCCCCC FEHVFVWKWSFHRK-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- OSDWBNJEKMUWAV-UHFFFAOYSA-N Allyl chloride Chemical compound ClCC=C OSDWBNJEKMUWAV-UHFFFAOYSA-N 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- IWDJHBXNPRZHEK-UHFFFAOYSA-N C(CC)C=1C(=C(C=CC1Br)CCC)CCC Chemical compound C(CC)C=1C(=C(C=CC1Br)CCC)CCC IWDJHBXNPRZHEK-UHFFFAOYSA-N 0.000 description 1
- RGBQGULUOUJOSU-UHFFFAOYSA-N C(CCCCCCC)C(CCCCBr)(CCCCCCCC)CCCCCCCC Chemical compound C(CCCCCCC)C(CCCCBr)(CCCCCCCC)CCCCCCCC RGBQGULUOUJOSU-UHFFFAOYSA-N 0.000 description 1
- DLYVTEULDNMQAR-SRNOMOOLSA-N Cholic Acid Methyl Ester Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCC(=O)OC)[C@@]2(C)[C@@H](O)C1 DLYVTEULDNMQAR-SRNOMOOLSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- XKLIUWMXAAQGLU-UHFFFAOYSA-N [dicyclohexyl(iodo)methyl]cyclohexane Chemical compound C1CCCCC1C(C1CCCCC1)(I)C1CCCCC1 XKLIUWMXAAQGLU-UHFFFAOYSA-N 0.000 description 1
- DKFCLGCDEMSYAW-UHFFFAOYSA-N [iodo(diphenyl)methyl]benzene Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(I)C1=CC=CC=C1 DKFCLGCDEMSYAW-UHFFFAOYSA-N 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- YSSSPARMOAYJTE-UHFFFAOYSA-N dibenzo-18-crown-6 Chemical compound O1CCOCCOC2=CC=CC=C2OCCOCCOC2=CC=CC=C21 YSSSPARMOAYJTE-UHFFFAOYSA-N 0.000 description 1
- UNTITLLXXOKDTB-UHFFFAOYSA-N dibenzo-24-crown-8 Chemical compound O1CCOCCOCCOC2=CC=CC=C2OCCOCCOCCOC2=CC=CC=C21 UNTITLLXXOKDTB-UHFFFAOYSA-N 0.000 description 1
- 229940117389 dichlorobenzene Drugs 0.000 description 1
- BBGKDYHZQOSNMU-UHFFFAOYSA-N dicyclohexano-18-crown-6 Chemical compound O1CCOCCOC2CCCCC2OCCOCCOC2CCCCC21 BBGKDYHZQOSNMU-UHFFFAOYSA-N 0.000 description 1
- QMLGNDFKJAFKGZ-UHFFFAOYSA-N dicyclohexano-24-crown-8 Chemical compound O1CCOCCOCCOC2CCCCC2OCCOCCOCCOC2CCCCC21 QMLGNDFKJAFKGZ-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 150000004673 fluoride salts Chemical class 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 150000004675 formic acid derivatives Chemical class 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229940102396 methyl bromide Drugs 0.000 description 1
- GZUXJHMPEANEGY-UHFFFAOYSA-N methyl bromide Substances BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 1
- XKBGEWXEAPTVCK-UHFFFAOYSA-M methyltrioctylammonium chloride Chemical compound [Cl-].CCCCCCCC[N+](C)(CCCCCCCC)CCCCCCCC XKBGEWXEAPTVCK-UHFFFAOYSA-M 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 235000003270 potassium fluoride Nutrition 0.000 description 1
- 239000011698 potassium fluoride Substances 0.000 description 1
- FVSKHRXBFJPNKK-UHFFFAOYSA-N propionitrile Chemical compound CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical class [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 1
- 238000006277 sulfonation reaction Methods 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 239000003021 water soluble solvent Substances 0.000 description 1
Landscapes
- Steroid Compounds (AREA)
Description
本発明は12位アルキルスルホン基を有するステ
ロイド化合物を脱スルホン化して△11不飽和ステ
ロイド化合物を製造する方法に関し、特に該ステ
ロイド化合物をアルカリ金属のフツ化物または低
級カルボン酸塩の少くとも1種及び該金属の炭酸
塩、重炭酸塩、亜硫酸塩、または水酸化物の少く
とも1種並びに第4アンモニウム塩またはクラウ
ンエーテルの少くとも1種からなる相関移動触媒
の共存下に脱スルホン化反応せしめることを特徴
とする方法に関する。
本発明の方法は11位の不飽和結合を有する各種
のステロイド化合物の合成に利用されるが、特に
コール酸よりケノデオキシコール酸(CDC)を
合成する際に有用である。
CDCは胆石溶解剤等の医薬品として有用な物
質であり、近年その安価な合成法の開発が期待さ
れている。
コール酸からCDCを合成する方法には主とし
て2通りの方法が知られており、その1つの方法
はコール酸の23位のカルボキシル基及び3位、7
位の水酸基をそれぞれエステル化して3α・7α
−ジアセトキシ−12α−ヒドロキシコラン酸メチ
ルを合成し、次いでこれを酸化して12−オキシ体
とした後ウオルフ、キシナー還元又は(ハンミン
ロン還元)により12位を水素で置換する方法であ
る。
他の1つはコール酸の12位の水酸基を脱水して
△11不飽和結合とし、これに水素添加する方法で
あり、例えば、アメリカ特許第3998859号に記載
された方法等が知られている。
即ち、コール酸をジアセトキシコラン酸メチル
とし、その12位の水酸基をアルキルスルホン基に
変換し、これを溶媒としてヘキサメチルホスホト
リアミド(HMPT)を使用して酢酸塩により脱
スルホン化して△11不飽和ステロイド化合物を
得、次いで該不飽和結合に水素添加し、更に加水
分解により保護基を外して目的物を得ている。
この方法は副反応も少く優れた方法ではある
が、溶媒として使用するHMPTは高価な物質で
あり、また、最近発ガン性の疑問がある旨の報告
もあり、工業的な製造法としては必ずしも適当な
方法であるとは言い難い。
そこで本発明者らかこの方法の改良法として工
業的に比較的安価で容易に入手できまた、人体に
有害な作用を有しない材料を用いて前記12位にア
ルキルスルホン基を有するステロイド化合物を脱
スルホン化して△11不飽和結合を有するステロイ
ド化合物を合成する方法について種々検討の結
果、該反応をアルカリ金属のフツ化物または、低
級カルボン酸塩の少くとも1種及び該金属の炭酸
塩、重炭酸塩、亜硫酸塩または水酸化物の少くと
も1種並びに第4アンモニウム塩またはクラウン
エーテルの少くとも1種からなる相関移動触媒の
共存下に行うことにより高収率で目的物を得るこ
とができ、所期の目的を達成し得ることに成功し
た。
以下、本発明の方法について更に詳しく説明す
る。
本発明の方法に於いて、前記金属塩及び第4ア
ンモニウム塩等は言わば、脱スルホン化剤として
働きを有するものであり、金属塩としてリチウ
ム、ナトリウム、またはカリウムのフツ化物、ギ
酸塩、酢酸塩、プロピオン酸塩、または酪酸塩等
が用いられ、就中、酢酸ソーダ、酢酸カリ、フツ
化ソーダまたはフツ化カリ等が実用上好適であ
る。また、炭酸塩、重炭酸塩、亜硫酸塩、または
水酸化物などのアルカリ性物質は上記脱スルホン
化剤の作用を改善し、副反応を抑制することに役
立つものである。第4アンモニウム塩としては次
の一般式で表わされる化合物が用いられる。
(ただし、R1、R2、R3およびR4はそれぞれ、アル
キル基、アルケニル基またはアリール基、Xは沃
素原子、臭素原子、塩素原子またはフツ素原子を
表わす。)
上記一般式で表わされる第4アンモニウム塩の
うち特に、R1、R2及びR3がそれぞれ炭素数1〜
8の鎖状若しくは環状のアルキル基、フエニル
基、ベンジル基または低級アルキル基で置換され
たフエニル基若しくはベンジル基であり、R4が
炭素数1〜18の鎖状若しくは環状アルキル基、炭
素数2〜4の低級アルケニル基またはベンジル基
であり、Xが塩素原子または臭素原子である化合
物が製造、精製の容易性、経済性、触媒としての
活性、安定性等の観点から最も実用的であると言
える。しかし、必ずしもこれらのみに制限される
ものではない。
本発明の方法に於ける代表的な第4アンモニウ
ム塩の例をいくつか示せば次の通りである。アン
モニウム−トリプロピルメチルヨウダイド、トリ
プロピルエチルクロライド、テトラプロピルブロ
マイド、トリプロピルブチルヨウダイド、トリプ
ロピルオクチルヨウダイド、トリプロピルシクロ
ヘキシルクロライド、トリプロピルフエニルブロ
マイド、トリブチルメチルヨウダイド、トリブチ
ルメチルブロマイド、トリブチルエチルブロマイ
ド、トリブチルプロピルクロライド、トリトリル
メチルヨウダイド、トリキシリルベンジルブロマ
イド、トリベンジルエチルクロライド、トリシク
ロヘキシルメチルヨウダイド、トリシクロペンチ
ルイソブチルクロライド、ジメチルエチルフエニ
ルヨウダイド、ジブチルメチルフエニルヨウダイ
ド、テトラブチルヨウダイド、トリブチルアミル
ブロマイド、トリブチルヘキシルクロライド、ト
リブチルオクチルヨウダイド、トリブチルデシル
ブロマイド、トリブチルセチルヨウダイド、トリ
ブチルベンジルクロライド、トリブチルアリルク
ロライド、トリブチルシクロヘキシルブロマイ
ド、トリアミルメチルブロマイド、トリヘプチル
ブチルクロライド、トリヘキシルメチルヨウダイ
ド、トリヘキシルブチルブロマイド、トリヘキシ
ルオクチルクロライド、トリオクチルメチルヨウ
ダイド、トリオクチルメチルブロマイド、トリオ
クチルエチルブロマイド、トリオクチルプロピル
クロライド、トリオクチルブチルヨウダイド、ト
リオクチルアミルブロマイド、テトラオクチルク
ロライド、トリオクチルセチルヨウダイド、トリ
オクチルベンジルクロライド、トリフエニルメチ
ルヨウダイド、トリフエニルプロピルブロマイ
ド、トリフエニルブチルヨウダイド、トリフエニ
ルヘプチルブロマイド、トリフエニルベンジルク
ロライド等、またクラウンエーテルとしては15−
クラウン−5・18−クラウン−6、ジベンゾ−18
−クラウン−6、ジシクロヘキシル−18−クラウ
ン−6、ジベンゾ−24−クラウン−8、ジシクロ
ヘキシル−24−クラウン−8等が用いられ、特
に、前記金属塩との組合せに於いて、金属のイオ
ン半径に合つたものを用いるのが効果的である。
反応は液相状態又は固−液相にて行われるが、
原料として使用される前記3α・7α−ジアセト
キシ−12α−メシルオキシコラン酸メチルは融点
が低く、反応温度では液体状態を保てるため溶媒
は必ずしも必要ではない。しかし、一般に無溶媒
では副反応が増加するため、通常は適当な溶媒を
用いることが好ましい。
溶媒の種類により反応速度に差はあるが、原則
的には反応条件下に液状で、原料、目的物や触媒
などを反応したり、分解したりしない安定なもの
であれば別に制限はない。液相にて行うときは水
と実質的に水と混和しない有機溶媒例えば、ベン
ゼン、トルエン、キシレン、クロルベンゼン、ジ
クロルベンゼン、メチルイソブチルケトン、酢酸
ブチル等が用いられる。また固液相系の場合は上
記のほかに水溶性の溶媒に使用でき、たとえば、
テトラヒドロフラン、ジオキサン、アセトニトリ
ル、プロピオニトリル、シクロヘキサノン等が用
いられる。
反応条件について言えば、必ずしも厳密な制限
はないが金属塩の使用量としては原料化合物1部
に対して、通常5部〜0.1部、好ましくは2部〜
0.5部程度が適当であり、アルカリ性物質は原料
化合物1部に対して、1部〜0.01部好ましくは
0.5部〜0.05部が適当であり、また、第4アンモ
ニウム塩又はクラウンエーテルの使用量としては
原料化合物1部に対して、通常0.2部〜0.001部好
ましくは0.1部〜0.01部程度が適当である。反応
温度は使用すべき原料の種類、触媒、溶媒等の組
合せにより最適範囲が異なるが、通常は80〜150
℃、好ましくは110〜130℃の範囲で行うのが適当
である。反応時間についても必ずしも1律には規
定し難いが、通常の条件下では4〜18時間程度が
適当と言える。
尚、本発明の方法は前述の如くコール酸より
CDCを合成する過程に於いて、3α・7α−ジ
アセトキシ−12α−メシルオキシコラン酸メチル
を脱スルホン化して11位に不飽和結合を有する化
合物に変換するのに効果的に適用されるが、この
場合、12位のアルキルスルホン基は何んでも良い
わけではなく、例えば、有機合成反応に於いて脱
離基として、しばしば利用されるP−トルエンス
ルホン基、ベンゼンスルホン基等の親油性の強い
基をもつアニオンの場合には脱離してきたアニオ
ンが第4アンモニウム塩等と結合してしまい、反
応に必要な金属塩残基を油相に転移させることが
なきなくなるため不適当である。従つて、12位の
アルキルスルホン基としてはメタン−エタン−等
の低級アルキル基が好適である。本発明の脱スル
ホン化反応は3位、7位の置換基によつて影響を
受けず、例えば、3位、7位が水素原子(非置
換)、水酸基、アルコキシ基、アシルオキシ基、
アルキル基等いずれでも良く、また、17位の置換
基はコール酸に相当する−CH(CH3)
CH2CH2CO2H又はその反応性誘導体例えば、エ
スチル、アミド、酸クロライド等のみに限らず他
のものでも良く、例えば、−CH(CH3)
CH2CH2H−CH(CH3)CO2HCO2H−COCH3、
CH2CH3−CH(OH)CH3等の基及びこれらの同
族体並びに反応性誘導体等いずれでも良く、各種
の△11不飽和ステロイド化合物の合成に巾広く適
用することができる。
以下、本発明の方法について実施例を示し更に
具体的に説明するが、これらは言わば本発明の方
法の単なる代表例であつて、本発明はこれらのみ
に限定されないことは勿論のこと、これらによつ
て何ら制限されないことは言うまでもない。
実施例 1
3α・7α−ジアセトキシ−12α−メシルオキ
シコラン酸メチル()100g、キシレン50ml、
酢酸カリ180g、炭酸ソーダ20g、水100ml、触媒
としてトリオクチルメチルアンモニウムクロライ
ド5gを混合し10時間120℃で加熱反応させる。
反応終了後、酢酸カリ層を分離し、有機層を水
洗する。有機層中のキシレンを減圧留去後、粗生
成物をメタノールで再結晶し精製品、3α・7α
−ジアセトキシ−△11コレン酸メチル71.5gを得
た。
実施例 2
原料()10gを各種条件下に8時間反応させ
た時の生成物分布を表に示す。
The present invention relates to a method for producing a △11-unsaturated steroid compound by desulfonating a steroid compound having an alkyl sulfone group at the 12-position, and particularly relates to a method for producing a Δ11- unsaturated steroid compound by desulfonating a steroid compound having an alkyl sulfone group at the 12-position. carrying out a desulfonation reaction in the coexistence of a phase transfer catalyst comprising at least one carbonate, bicarbonate, sulfite, or hydroxide of the metal and at least one quaternary ammonium salt or crown ether; Relating to a method characterized by: The method of the present invention is used to synthesize various steroid compounds having an unsaturated bond at the 11th position, and is particularly useful for synthesizing chenodeoxycholic acid (CDC) from cholic acid. CDC is a useful substance as a drug such as a gallstone dissolving agent, and the development of an inexpensive synthesis method is expected in recent years. There are two main methods known for synthesizing CDC from cholic acid.
By esterifying the hydroxyl groups at positions 3α and 7α, respectively
This is a method in which methyl -diacetoxy-12α-hydroxycholanate is synthesized, then oxidized to form a 12-oxy compound, and then the 12th position is substituted with hydrogen by Wolff or Chisner reduction or (Hamminlon reduction). The other method is to dehydrate the 12-position hydroxyl group of cholic acid to form a Δ11 unsaturated bond, and then hydrogenate this. For example, the method described in U.S. Patent No. 3,998,859 is known. . That is, cholic acid was converted into methyl diacetoxycholanate, the hydroxyl group at the 12th position was converted to an alkylsulfone group, and this was desulfonated with acetate using hexamethylphosphotriamide (HMPT) as a solvent. An unsaturated steroid compound is obtained, then the unsaturated bond is hydrogenated, and the protecting group is removed by hydrolysis to obtain the desired product. Although this method is an excellent method with fewer side reactions, the HMPT used as a solvent is an expensive substance, and there have been recent reports that it may be carcinogenic, so it is not necessarily suitable as an industrial production method. It is hard to say that this is an appropriate method. Therefore, the present inventors devised a method to improve this method by removing the steroid compound having an alkyl sulfone group at the 12-position using a material that is industrially relatively inexpensive, easily available, and has no harmful effects on the human body. As a result of various studies on the method of synthesizing steroid compounds having △ 11 unsaturated bonds by sulfonation, it was found that the reaction was carried out using at least one kind of alkali metal fluorides or lower carboxylates and carbonates and bicarbonates of the metals. The desired product can be obtained in high yield by carrying out in the coexistence of a phase transfer catalyst consisting of at least one salt, sulfite or hydroxide and at least one quaternary ammonium salt or crown ether, succeeded in achieving the intended purpose. The method of the present invention will be explained in more detail below. In the method of the present invention, the metal salts and quaternary ammonium salts function as desulfonating agents, and the metal salts include fluorides, formates, and acetates of lithium, sodium, or potassium. , propionate, butyrate, etc. are used, and among them, sodium acetate, potassium acetate, sodium fluoride, potassium fluoride, etc. are practically preferred. In addition, alkaline substances such as carbonates, bicarbonates, sulfites, or hydroxides are useful in improving the action of the desulfonating agent and suppressing side reactions. As the quaternary ammonium salt, a compound represented by the following general formula is used. (However, R 1 , R 2 , R 3 and R 4 each represent an alkyl group, an alkenyl group or an aryl group, and X represents an iodine atom, bromine atom, chlorine atom or fluorine atom.) Represented by the above general formula Especially among the quaternary ammonium salts, R 1 , R 2 and R 3 each have 1 to 1 carbon atoms.
8 is a chain or cyclic alkyl group, phenyl group, benzyl group, or phenyl group or benzyl group substituted with a lower alkyl group, and R 4 is a chain or cyclic alkyl group having 1 to 18 carbon atoms, or a chain or cyclic alkyl group having 2 carbon atoms. ~4 lower alkenyl group or benzyl group, and compounds in which X is a chlorine atom or a bromine atom are considered to be the most practical from the viewpoints of ease of production and purification, economic efficiency, activity as a catalyst, stability, etc. I can say it. However, it is not necessarily limited to these. Some representative examples of quaternary ammonium salts used in the method of the present invention are as follows. Ammonium - tripropylmethyl iodide, tripropylethyl chloride, tetrapropyl bromide, tripropyl butyl iodide, tripropyloctyl iodide, tripropylcyclohexyl chloride, tripropylphenyl bromide, tributylmethyl iodide, tributyl methyl bromide, tributyl Ethyl bromide, tributylpropyl chloride, tritolylmethyl iodide, tricylylbenzyl bromide, tribenzylethyl chloride, tricyclohexylmethyl iodide, tricyclopentyl isobutyl chloride, dimethylethylphenyl iodide, dibutylmethylphenyl iodide, tetrabutyl Iodide, tributyl amyl bromide, tributylhexyl chloride, tributyl octyl iodide, tributyl decyl bromide, tributyl cetyl iodide, tributyl benzyl chloride, tributyl allyl chloride, tributyl cyclohexyl bromide, triamyl methyl bromide, triheptyl butyl chloride, trihexyl methyl Iodide, trihexylbutyl bromide, trihexyl octyl chloride, trioctyl methyl iodide, trioctyl methyl bromide, trioctyl ethyl bromide, trioctyl propyl chloride, trioctyl butyl iodide, trioctyl amyl bromide, tetraoctyl chloride, tri- Octylcetyl iodide, trioctylbenzyl chloride, triphenylmethyl iodide, triphenylpropyl bromide, triphenylbutyl iodide, triphenylheptyl bromide, triphenylbenzyl chloride, etc., and as a crown ether, 15-
Crown-5・18-Crown-6, Dibenzo-18
-Crown-6, dicyclohexyl-18-crown-6, dibenzo-24-crown-8, dicyclohexyl-24-crown-8, etc. are used, and especially in combination with the above metal salts, the ionic radius of the metal It is effective to use the one that suits you. The reaction is carried out in liquid phase or solid-liquid phase, but
The methyl 3α·7α-diacetoxy-12α-mesyloxycholanate used as a raw material has a low melting point and can maintain a liquid state at the reaction temperature, so a solvent is not necessarily required. However, since side reactions generally increase when no solvent is used, it is usually preferable to use an appropriate solvent. The reaction rate varies depending on the type of solvent, but in principle there are no particular restrictions as long as it is liquid under the reaction conditions and is stable as long as it does not react with or decompose the raw materials, target product, catalyst, etc. When the reaction is carried out in a liquid phase, organic solvents substantially immiscible with water such as benzene, toluene, xylene, chlorobenzene, dichlorobenzene, methyl isobutyl ketone, butyl acetate, etc. are used. In addition, in the case of solid-liquid phase systems, water-soluble solvents can be used in addition to the above, for example,
Tetrahydrofuran, dioxane, acetonitrile, propionitrile, cyclohexanone, etc. are used. As for the reaction conditions, there are no strict limitations, but the amount of metal salt used is usually 5 parts to 0.1 parts, preferably 2 parts to 1 part of the raw material compound.
Approximately 0.5 part is appropriate, and the alkaline substance is preferably 1 part to 0.01 part per 1 part of the raw material compound.
0.5 part to 0.05 part is appropriate, and the amount of quaternary ammonium salt or crown ether used is usually about 0.2 part to 0.001 part, preferably about 0.1 part to 0.01 part, based on 1 part of the raw material compound. . The optimal range of reaction temperature varies depending on the type of raw materials used, the combination of catalysts, solvents, etc., but it is usually 80 to 150.
It is appropriate to carry out the reaction at a temperature of 110 to 130°C. Although it is difficult to define the reaction time uniformly, it can be said that about 4 to 18 hours is appropriate under normal conditions. The method of the present invention uses cholic acid as described above.
In the process of synthesizing CDC, it is effectively applied to desulfonate methyl 3α・7α-diacetoxy-12α-mesyloxycholanate to convert it into a compound having an unsaturated bond at the 11-position. In this case, the alkylsulfone group at the 12th position is not arbitrary; for example, it may be a highly lipophilic group such as P-toluenesulfone group or benzenesulfone group, which is often used as a leaving group in organic synthesis reactions. In the case of an anion having , the desorbed anion will bond with the quaternary ammonium salt, etc., and the metal salt residue necessary for the reaction will not be transferred to the oil phase, which is inappropriate. Therefore, a lower alkyl group such as methane-ethane- is suitable as the alkylsulfone group at the 12th position. The desulfonation reaction of the present invention is not affected by substituents at the 3-position and 7-position, for example, hydrogen atoms (unsubstituted), hydroxyl group, alkoxy group, acyloxy group,
Any alkyl group may be used, and the substituent at position 17 is -CH(CH 3 ) corresponding to cholic acid.
It is not limited to CH 2 CH 2 CO 2 H or its reactive derivatives such as ethyl, amide, acid chloride, etc., but also other compounds such as -CH(CH 3 )
CH2CH2H − CH ( CH3 ) CO2HCO2H − COCH3 ,
Any of groups such as CH 2 CH 3 -CH(OH)CH 3 and their homologues and reactive derivatives may be used, and can be widely applied to the synthesis of various Δ11 unsaturated steroid compounds. Hereinafter, the method of the present invention will be described in more detail by showing examples, but these are merely representative examples of the method of the present invention, and it goes without saying that the present invention is not limited to these. Needless to say, there are no restrictions whatsoever. Example 1 100 g of methyl 3α・7α-diacetoxy-12α-mesyloxycholanate (), 50 ml of xylene,
180 g of potassium acetate, 20 g of soda carbonate, 100 ml of water, and 5 g of trioctylmethylammonium chloride as a catalyst were mixed and reacted by heating at 120°C for 10 hours. After the reaction is completed, the potassium acetate layer is separated and the organic layer is washed with water. After removing xylene in the organic layer under reduced pressure, the crude product was recrystallized with methanol to obtain purified products, 3α and 7α.
-Diacetoxy- Δ11 71.5 g of methyl cholate was obtained. Example 2 The table shows the product distribution when 10 g of raw material () was reacted for 8 hours under various conditions.
【表】【table】
Claims (1)
ド化合物をアルカリ金属のフツ化物または低級カ
ルボン酸塩の少くとも1種及び該金属の炭酸塩、
重炭酸塩、亜硫酸塩または水酸化物の少くとも1
種並びに第4アンモニウム塩、またはクラウンエ
ーテルの少くとも1種からなる相関移動触媒の共
存下に脱スルホン化反応せしめることを特徴とす
る△11不飽和ステロイド化合物の製造方法。1 A steroid compound having an alkyl sulfone group at the 12-position is combined with at least one alkali metal fluoride or lower carboxylate salt and a carbonate of the metal;
At least one bicarbonate, sulfite or hydroxide
A method for producing a Δ11 unsaturated steroid compound, which comprises carrying out a desulfonation reaction in the coexistence of a phase transfer catalyst comprising at least one species and a quaternary ammonium salt or a crown ether.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP16913980A JPS5793998A (en) | 1980-12-02 | 1980-12-02 | Preparation of delta11 unsaturated steroid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP16913980A JPS5793998A (en) | 1980-12-02 | 1980-12-02 | Preparation of delta11 unsaturated steroid |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5793998A JPS5793998A (en) | 1982-06-11 |
JPS6221357B2 true JPS6221357B2 (en) | 1987-05-12 |
Family
ID=15881003
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP16913980A Granted JPS5793998A (en) | 1980-12-02 | 1980-12-02 | Preparation of delta11 unsaturated steroid |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5793998A (en) |
-
1980
- 1980-12-02 JP JP16913980A patent/JPS5793998A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS5793998A (en) | 1982-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Liu et al. | A novel route to olefins from vicinal diols | |
JPS6221357B2 (en) | ||
US5808117A (en) | Process for the production of 16-Dehydropregenolone acetate form diosgenin | |
JPS6221358B2 (en) | ||
EP1026140B1 (en) | Process of producing adamantanols | |
JP3350440B2 (en) | Method for producing 1,2,3,6-tetrahydro-2,2,6,6-methylpyridine-N-oxyl | |
JPS6227078B2 (en) | ||
JP2008074722A (en) | Method for producing 2-amino-5-iodobenzoic acid | |
KR920004603B1 (en) | Production of 2,2-dimethoxy-2-phenylaceto phenone | |
JPS6053039B2 (en) | N-Acetyl/Iramic acid derivative and method for producing the same | |
ES2234423B1 (en) | PROCEDURE FOR OBTAINING VITAMIN DERIVATIVES FROM MONOHALOGENOVINYL COMPOUNDS. | |
JP4397990B2 (en) | Purification method of 3-alkylflavanonol derivatives | |
JPS59186942A (en) | Purification of crude 1,4-dihydroxy-2-naphthoic acid or its salt | |
JP2006213669A (en) | METHOD FOR PRODUCING 2,6-DI-tert-BUTYL-4-MERCAPTOPHENOL AND 4,4'-ISOPROPYLIDENEDITHIOBIS[2,6-DI-tert-BUTYLPHENOL] | |
EP0060301A1 (en) | Process for preparing cephalosporin compounds | |
US2205045A (en) | Preparation of acylated 3-hydroxybis-nor cholenic acids | |
EP0349991B1 (en) | Process for producing vitamin A or its carboxylic acid esters | |
JPH0610164B2 (en) | Isoprenyl benzoate derivative and process for producing the same | |
JPH02282372A (en) | Production of o-acylthiamine disulfides | |
JPH0656758A (en) | Production of 2-naphthol-6-sulfonate | |
JPS6346153B2 (en) | ||
JPH09176142A (en) | Production of aminothiazoleacetic acid derivative | |
JPH0948745A (en) | Production of carboxylic acid ester | |
JPS5916852A (en) | Cis-bicyclo(3,3,0)octane compound | |
JPS6126555B2 (en) |